ATE236633T1 - Topische verwendung von loperamid zur behandlung mikrobieller infektionen - Google Patents

Topische verwendung von loperamid zur behandlung mikrobieller infektionen

Info

Publication number
ATE236633T1
ATE236633T1 AT99904829T AT99904829T ATE236633T1 AT E236633 T1 ATE236633 T1 AT E236633T1 AT 99904829 T AT99904829 T AT 99904829T AT 99904829 T AT99904829 T AT 99904829T AT E236633 T1 ATE236633 T1 AT E236633T1
Authority
AT
Austria
Prior art keywords
loperamide
microbial infections
topical use
treat microbial
treat
Prior art date
Application number
AT99904829T
Other languages
English (en)
Inventor
Carol Keene
George S Avenue Saint
Angus Malcolm
S Avenue George
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Application granted granted Critical
Publication of ATE236633T1 publication Critical patent/ATE236633T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/451Non condensed piperidines, e.g. piperocaine having a carbocyclic group directly attached to the heterocyclic ring, e.g. glutethimide, meperidine, loperamide, phencyclidine, piminodine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/10Anti-acne agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT99904829T 1998-02-05 1999-01-29 Topische verwendung von loperamid zur behandlung mikrobieller infektionen ATE236633T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9802542.2A GB9802542D0 (en) 1998-02-05 1998-02-05 New use
PCT/EP1999/000608 WO1999039711A1 (en) 1998-02-05 1999-01-29 Antimicrobial composition

Publications (1)

Publication Number Publication Date
ATE236633T1 true ATE236633T1 (de) 2003-04-15

Family

ID=10826560

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99904829T ATE236633T1 (de) 1998-02-05 1999-01-29 Topische verwendung von loperamid zur behandlung mikrobieller infektionen

Country Status (9)

Country Link
US (1) US6566374B1 (de)
EP (1) EP1052991B1 (de)
AT (1) ATE236633T1 (de)
DE (1) DE69906701T2 (de)
DK (1) DK1052991T3 (de)
ES (1) ES2196769T3 (de)
GB (1) GB9802542D0 (de)
PT (1) PT1052991E (de)
WO (1) WO1999039711A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9802542D0 (en) 1998-02-05 1998-04-01 Smithkline Beecham Plc New use
US7138459B2 (en) * 2004-04-02 2006-11-21 Adherent Laboratories, Inc. Water soluble contact lens blocking composition
US7220800B2 (en) * 2004-04-02 2007-05-22 Adherent Laboratories, Inc. Water soluble contact lens blocking composition with absorbent disintegrant
WO2007003941A1 (en) * 2005-07-06 2007-01-11 Cambridge Enterprise Limited Modulation of autophagy by calpain inhibition
US20080033021A1 (en) * 2006-08-02 2008-02-07 Susan Burke Wash composition for the handling of contact lenses
FR2969494B1 (fr) * 2010-12-22 2013-11-08 Expanscience Lab Extrait de parties aeriennes de gynandropsis gynandra ou cleome gynandra et compositions cosmetiques, dermatologiques le comprenant

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3906779A1 (de) 1989-03-03 1990-09-06 Hoechst Ag Mittel gegen tierparasiten
US5849761A (en) * 1995-09-12 1998-12-15 Regents Of The University Of California Peripherally active anti-hyperalgesic opiates
US6156771A (en) * 1997-08-28 2000-12-05 Rubin; Walter Method for alleviation of lower gastrointestinal disorders in a human patient
GB9802542D0 (en) 1998-02-05 1998-04-01 Smithkline Beecham Plc New use

Also Published As

Publication number Publication date
WO1999039711A1 (en) 1999-08-12
EP1052991A1 (de) 2000-11-22
ES2196769T3 (es) 2003-12-16
GB9802542D0 (en) 1998-04-01
PT1052991E (pt) 2003-08-29
DE69906701D1 (de) 2003-05-15
US6566374B1 (en) 2003-05-20
DK1052991T3 (da) 2003-08-04
DE69906701T2 (de) 2004-02-05
EP1052991B1 (de) 2003-04-09

Similar Documents

Publication Publication Date Title
DE59710183D1 (de) Topische mittel zur prophylaxe oder behandlung bakterieller hautinfektionen
ATE265857T1 (de) Pharmazeutische oder diätetische zusammensetzung zur prävention oder behandlung von hyperoxalurie
DE60021266D1 (de) Verwendungen von zusammensetzungen zur behandlung oder vermeidung von schlafstörungen mit sehr niedrigdosierten cyclobenzaprine
ATE350030T1 (de) Nordihydroguaiaretinsäurederivate zur behandlung von tumoren
ATE201597T1 (de) Verabreichung von riluzol zur behandlung von neuro-aids
DE69711078D1 (de) Topische verwendung von kappa-opioidrezeptoragonisten zur behandlung von augenschmerz
ATE218862T1 (de) Verwendung von 1-hydroxy-2-pyridonen zur behandlung von hautinfektionen
ATE541565T1 (de) Topische verwendung von muskarinischen und opioiden mitteln zur behandlung von tinnitus
ATE201598T1 (de) Verwendung von moxonidin zur behandlung neuropathischer schmerzen
DE69925578D1 (de) Pharmazeutische zusammenstellung zur vorbeugung und behandlung von mit zellkrankheiten des augenhintergrundes zusammenhängenden krankheiten
ATE222101T1 (de) Verwendung von selegilin oder desmethylselegilin zur behandlung von wunden, verbrennungen und hautschäden
ATE234617T1 (de) Verwendung des saredutant und seiner pharmazeutisch akzeptablen salze zur behandlung von schwere depression
ATE236633T1 (de) Topische verwendung von loperamid zur behandlung mikrobieller infektionen
ATE359808T1 (de) Verwendung von sarp-1 zur behandlung und/oder vorbeugung von scleroderma
ATE347888T1 (de) Verwendung von aivlosin zur behandlung und prevention der lawsonia-infektionen in schweinen.
DE69913380D1 (de) Zusammensetzung zur behandlung von periodontalen erkrankungen
DE69626816D1 (de) Verwendung von selegilin zur behandlung von gehörverlust bei säugetieren
ATE294584T1 (de) Verwendung von desoxypeganin zur behandlung von alzheimerischer demenz
ATE278401T1 (de) Verwendung von riluzol zur behandlung von akustischen traumazuständen
DE69424679D1 (de) Zusammensetzung zur behandlung oder vorbeugung von herpes
ATE291425T1 (de) R-eliprodil zur behandlung von glaucoma
DE69427116D1 (de) Verwendung von 4'-iodo - 4 - deoxydoxorubicin zur behandlung von amyloidosis
DE69737088D1 (de) Therapeutisches agens zur behandlung von fiv infektionen
DE59911556D1 (de) Arzneimittel zur vermeidung oder behandlung von papillomavirus-spezifischem tumor
ES2188754T3 (es) Componente b como cicatrizante.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1052991

Country of ref document: EP

REN Ceased due to non-payment of the annual fee